Global diabetes rates have surged, particularly in low-resource areas, revealing critical gaps in treatment access and ...

Fourteen percent of the world's people -- more than 800 million -- now have diabetes, a doubling of the global rate for the ...

KHOU 11 News anchor Rekha Muddaraj spoke to an endocrinologist with UT Physicians about the chronic disease and what to look ...

An advancement in diabetes treatment has been achieved by Professor Hyun-Wook Kang and his team from the Department of ...

Common treatments, such as statins, are effective at lowering LDL cholesterol and have also shown to reduce inflammation, ...

Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

Spanning 176 weeks of treatment, the Phase III trial evaluated the efficacy and safety of tirzepatide in adults without type ...

Global diabetes cases have quadrupled since 1990, affecting over 800 million adults worldwide, according to a World Health ...

Mloganzila has expanded its diagnostic and treatment services for diabetes patients by introducing two new clinics, including ...

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

The global burden of diabetes and untreated diabetes increased from 1990 to 2022, according to a study published onlin ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...